A Ramón, M Zaragozá, AM Torres, J Cascón… - Journal of Clinical …, 2022 - mdpi.com
Among the IL-6 inhibitors, tocilizumab is the most widely used therapeutic option in patients
with SARS-CoV-2-associated severe respiratory failure (SRF). The aim of our study was to …